Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Nat Biotechnol ; 28(9): 935-42, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20829833

ABSTRACT

Biological Pathway Exchange (BioPAX) is a standard language to represent biological pathways at the molecular and cellular level and to facilitate the exchange of pathway data. The rapid growth of the volume of pathway data has spurred the development of databases and computational tools to aid interpretation; however, use of these data is hampered by the current fragmentation of pathway information across many databases with incompatible formats. BioPAX, which was created through a community process, solves this problem by making pathway data substantially easier to collect, index, interpret and share. BioPAX can represent metabolic and signaling pathways, molecular and genetic interactions and gene regulation networks. Using BioPAX, millions of interactions, organized into thousands of pathways, from many organisms are available from a growing number of databases. This large amount of pathway data in a computable form will support visualization, analysis and biological discovery.


Subject(s)
Computational Biology/methods , Computational Biology/standards , Information Dissemination , Metabolic Networks and Pathways , Signal Transduction , Software , Databases as Topic , Programming Languages
2.
J Chem Inf Model ; 46(4): 1549-62, 2006.
Article in English | MEDLINE | ID: mdl-16859287

ABSTRACT

The most desirable compound leads from high-throughput assays are those with novel biological activities resulting from their action on a single biological target. Valuable resources can be wasted on compound leads with significant 'side effects' on additional biological targets; therefore, technical refinements to identify compounds that primarily have effects resulting from a single target are needed. This study explores the use of multiple assays of a chemical library and a statistic based on entropy to identify lead compound classes that have patterns of assay activity resulting primarily from small molecule action on a single target. This statistic, called the coincidence score, discriminates with 88% accuracy compound classes known to act primarily on a single target from compound classes with significant side effects on nonhomologous targets. Furthermore, a significant number of the compound classes predicted to have primarily single-target effects contain known bioactive compounds. We also show that a compound's known biological target or mechanism of action can often be suggested by its pattern of activities in multiple assays.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Pharmacology , Pharmaceutical Preparations/chemistry , Thermodynamics
3.
J Chem Inf Model ; 45(6): 1824-36, 2005.
Article in English | MEDLINE | ID: mdl-16309290

ABSTRACT

Scoring the activity of compounds in phenotypic high-throughput assays presents a unique challenge because of the limited resolution and inherent measurement error of these assays. Techniques that leverage the structural similarity of compounds within an assay can be used to improve the hit-recovery rate from screening data. A technique is presented that uses clustering and sampling statistics to predict likely compound activity by scoring entire structural classes. A set of phenotypic assays performed against a commercially available compound library was used as a test set. Using the class-scoring technique, the resultant activity prediction scores were more reproducible than individual assay measurements, and class scoring recovered known active compounds more efficiently than individual assay measurements because class scoring had fewer false positives. Known biologically active compounds were recovered 87% of the time using class scores, suggesting a low false-negative rate that compared well to individual assay measurements. In addition, many weak and potentially novel classes of active compounds, overlooked by individual assay measurements, were suggested.


Subject(s)
Drug Evaluation, Preclinical/statistics & numerical data , Models, Statistical , Actins/chemistry , Actins/drug effects , Algorithms , Cluster Analysis , Endocytosis/drug effects , Entropy , Enzyme Inhibitors , Methyltransferases/antagonists & inhibitors , Microtubules/drug effects , Mitochondria/drug effects , Phenotype , Structure-Activity Relationship , Terminology as Topic
4.
Science ; 300(5616): 100-2, 2003 Apr 04.
Article in English | MEDLINE | ID: mdl-12677061

ABSTRACT

Biological imaging is now a quantitative technique for probing cellular structure and dynamics and is increasingly used for cell-based screens. However, the bioinformatics tools required for hypothesis-driven analysis of digital images are still immature. We are developing the Open Microscopy Environment (OME) as an informatics solution for the storage and analysis of optical microscope image data. OME aims to automate image analysis, modeling, and mining of large sets of images and specifies a flexible data model, a relational database, and an XML-encoded file standard that is usable by potentially any software tool. With this design, OME provides a first step toward biological image informatics.


Subject(s)
Computational Biology , Databases, Factual , Information Storage and Retrieval , Microscopy , Algorithms , Software
SELECTION OF CITATIONS
SEARCH DETAIL